FDA Updates on Hormone Therapy

The federal government recently signaled broader support for women’s hormone replacement therapy (HRT), including steps to remove outdated FDA warnings—an encouraging move for women’s health.

But despite the headlines, most women will not experience meaningful changes in access anytime soon: commercial insurance coverage remains inconsistent, and the majority of primary care physicians and general gynecologists simply don’t have the specialized training to manage modern, evidence-based HRT. There’s also a shortage of physicians truly comfortable prescribing it—and this is not the type of care that should be delegated to PAs or NPs.

At Sur Health, our physicians are North American Menopause Society–certified experts who provide precise, lab-guided HRT with transparent, all-in pricing and close follow-up. If you want HRT that’s safe, personalized, and managed by specialists—not generalists—we’re here to support you.